Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Services
  • Locations
  • Physicians
  • Patient and Visitor Info
  • Clinical Trials
  • Event Calendar
  • Health Library
  • About Duke Medicine
    • Honors & Awards
    • Nursing
    • Quality and Safety
    • Careers
    • Giving
    • About DukeHealth.org
    • Contact Us

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > About Duke Medicine > Quality and Safety > Performance Measures > Heart Failure > Heart Failure Patients Given ACE Inhibitor or ARB for Left Ventricular Systolic Dysfunction (LVSD)
Jumbo Large Regular Text:
Print E-mail
Quality and Safety
  • Patient Care Quality and Safety
  •   |   Performance Measures
  •   |   Safety and Quality Awards
  •   |   Improvement Initiatives
  •   |   Contact Us with Concerns

Heart Failure Patients Given ACE Inhibitor or ARB for Left Ventricular Systolic Dysfunction (LVSD)

Share

Note: The chart on this page requires the Flash viewer. To see it, download and install the Flash plugin here:
Macromedia Flash Player

InstitutionRating
U.S. Average195%
N.C. Average296%
Top Hospitals3100%
Duke Raleigh Hospital100%
Duke University Hospital97%
Durham Regional Hospital97%

The rates displayed in this graph are for discharges January 2010 through December 2010. Source: hospitalcompare.hhs.gov
(1) The U.S. average includes all reporting hospitals in the United States.
(2) The N.C. average includes all reporting hospitals in the state of North Carolina.
(3) "Top Hospitals" represent the top 10% of hospitals nationwide. These hospitals achieved 100% on this measure.

What Does This Measure?

The percentage of eligible heart failure patients with left ventricular systolic dysfunction (LVSD) who received an ACE (angiotensin converting enzyme) inhibitor or ARB (angiotensin receptor blocker) on discharge.

Why Is This Important?

ACE inhibitors and ARBs are medicines that block a hormone in the body that causes blood vessels to narrow. They help lower blood pressure and reduce the heart’s workload.

Prescribing ACE inhibitors and ARBs to patients with heart failure symptoms or reduced heart function due to a heart attack significantly reduces the risk of death.

What Are We Doing to Improve Our Performance?

Duke has enacted several initiatives to improve our performance. These include:

  • Computerized physician order entry (CPOE)
  • Electronic medical records (EMR)
  • Evidence-based medicine
  • HealthView patient portal
  • Heart failure-specific discharge instructions and patient education information
  • Nursing and physician education
  • Patient advocacy and support groups
  • Patient rounding
  • Patient safety and clinical quality committees
  • Six Sigma
  • Standardized order sets

More Information

  • See more heart failure quality measures
  • See all performance measures
  • Compare Duke to other North Carolina hospitals at NC Hospital Quality Report
  • Compare Duke to regional and national hospitals at Hospital Quality Alliance's Hospital Compare
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2012 Duke University Health System

About This Page

Updated: Sept. 2, 2011
Published: Mar. 6, 2008
URL: http://www.dukehealth.org/about_duke/quality/performance_measures/heart_failure/ace_inhibitor